Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice

British Journal of Nutrition

Volumn 114, Issue 6, 2015, Pages 853-865

  Impellizzeri, Daniela ^a   Talero, Elena ^b   Siracusa, Rosalba ^a   Alcaide, Antonio ^b   Cordaro, Marika ^a   Maria Zubelia, Jose ^c   Bruschetta, Giuseppe ^a   Crupi, Rosalia ^a   Esposito, Emanuela ^a   Cuzzocrea, Salvatore ^a   Motilva, Virginia ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF SEVILLE   (Spain)

^c PoliNat SL   (Spain)

Author keywords

Apoptosis; Inflammation; Lung injury; Oxidative stress; Polyphenols

Indexed keywords

3 NITROTYROSINE; BLEOMYCIN; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGIFERA INDICA EXTRACT; MANGIFERIN; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLACEBO; POLYPHENOL DERIVATIVE; PROTEIN BCL 2; PROTEIN BID; QUERCETIN; RESVERATROL; TAXIFOLIN; TRANSCRIPTION FACTOR RELA; VITIS VINIFERA EXTRACT; ANTIOXIDANT; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; POLYPHENOL; STILBENE DERIVATIVE; XANTHONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG DETERMINATION; DRUG EFFECT; DRUG ISOLATION; DRUG TARGETING; EXPERIMENTAL PULMONARY FIBROSIS; GRAPE; LUNG EDEMA; LUNG LAVAGE; MALE; MANGO; MOUSE; MOUSE MODEL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLANT LEAF; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WEIGHT REDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DIETARY SUPPLEMENT; DISEASE MODEL; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LUNG; MANGIFERA; METABOLISM; PATHOLOGY; PULMONARY FIBROSIS; RANDOMIZATION; RESPIRATORY TRACT MUCOSA; VITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; APOPTOSIS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; LUNG; MALE; MANGIFERA; MICE, INBRED ICR; NEUTROPHIL INFILTRATION; PLANT EXTRACTS; PLANT LEAVES; POLYPHENOLS; PULMONARY FIBROSIS; QUERCETIN; RANDOM ALLOCATION; RESPIRATORY MUCOSA; STILBENES; VITIS; XANTHONES;

EID: 84941000310     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515002597     Document Type: Article

References (57)

1. Sleijfer S. (2001). Bleomycin-induced pneumonitis. Chest 120, 617-624
2. Lazenby AJ, Crouch EC, McDonald JA, et al. (1990). Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am Rev Respir Dis 142, 206-214
3. Walsh J, Absher M, & Kelley J. (1993). Variable expression of platelet-derived growth factor family proteins in acute lung injury. Am J Respir Cell Mol Biol 9, 637-644
4. Pron G, Belehradek J Jr, Orlowski S, et al. (1994). Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem Pharmacol 48, 301-310
5. Goodman MT, Hernandez B, Wilkens LR, et al. (1998). Effects of beta-carotene, and alpha-Tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol Biomarkers Prev 7, 113-117
6. Hubbard AK, Timblin CR, Shukla A, et al. (2002). Activation of NF-kappaB-dependent gene expression by silica in lungs of luciferase reporter mice. Am J Physiol Lung Cell Mol Physiol 282, L968-L975
7. Saleh D, Barnes PJ, & Giaid A. (1997). Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155, 1763-1769
8. Middleton E Jr, Kandaswami C, & Theoharides TC. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52, 673-751
9. Chuang CC, & McIntosh MK. (2011). Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation, and metabolic diseases. Annu Rev Nutr 31, 155-176
10. Valenzano DR, Terzibasi E, Genade T, et al. (2006). Resveratrol prolongs lifespan, and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 16, 296-300
11. Elmali N, Baysal O, Harma A, et al. (2007). Effects of resveratrol in inflammatory arthritis. Inflammation 30, 1-6
12. Vang O. (2013). What is new for resveratrol?. Is a new set of recommendations necessary?. Ann NY Acad Sci 1290, 1-11
13. Boots AW, Haenen GR, & Bast A. (2008). Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585, 325-337
14. Wang RR, Gao YD, Ma CH, et al. (2011). Mangiferin, an anti- HIV-1 agent targeting protease, and effective against resistant strains. Molecules 16, 4264-4277
15. Li X, Cui X, Sun X, et al. (2010). Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats. Phytother Res 24, 893-899
16. Slimestad R, Fossen T, & Vagen IM. (2007). Onions: a source of unique dietary flavonoids. J Agric Food Chem 55, 10067-10080
17. Wallace SN, Carrier DJ, & Clausen EC. (2005). Batch solvent extraction of flavanolignans from milk thistle (Silybum marianum L. Gaertner). Phytochem Anal 16, 7-16
18. Rohdewald P. (2002). A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40, 158-168
19. Murach EI, Baranov IA, Erlykina EI, et al. (2014). Adaptogenic effects of dihydroquercetin-chitosan composition during modeling of acute hypoxia. Bull Exp Biol Med 156, 306-309
20. Weidmann AE. (2012). Dihydroquercetin: more than just an impurity?. Eur J Pharmacol 684, 19-26
21. Sener G, Topaloglu N, Sehirli AO, et al. (2007). Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther 20, 642-649
22. Akgedik R, Akgedik S, Karamanli H, et al. (2012). Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats. Inflammation 35, 1732-1741
23. Yuan ZP, Chen LJ, Fan LY, et al. (2006). Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res 12, 3193-3199
24. Baowen Q, Yulin Z, Xin W, et al. (2010). A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin, and inflammatory cytokines in pulmonary fibrosis. Eur J Pharmacol 642, 134-139
25. Verma R, Kushwah L, Gohel D, et al. (2013). Evaluating the ameliorative potential of quercetin against the bleomycininduced pulmonary fibrosis in Wistar rats. Pulm Med 2013, 921724
26. Guo HW, Yun CX, Hou GH, et al. (2014). Mangiferin attenuates TH1/TH2 cytokine imbalance in an ovalbumin-induced asthmatic mouse model. PLOS ONE 9, e100394
27. Gong X, Zhang L, Jiang R, et al. (2013). Anti-inflammatory effects of mangiferin on sepsis-induced lung injury in mice via up-regulation of heme oxygenase-1. J Nutr Biochem 24, 1173-1181
28. Ma L, Li Y, Zhao Y, et al. (2013). 3,5,4′-Tri-O-Acetylresveratrol ameliorates seawater exposure-induced lung injury by upregulating connexin 43 expression in lung. Mediators Inflamm 2013, 182132
29. Galindo P, Gonzalez-Manzano S, Zarzuelo MJ, et al. (2012). Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats. Food Funct 3, 643-650
30. Ashcroft T, Simpson JM, & Timbrell V. (1988). Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41, 467-470
31. Mullane KM, Kraemer R, & Smith B. (1985). Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14, 157-167
32. Green FH. (2002). Overview of pulmonary fibrosis. Chest 122, 334S-339S
33. Antoniou KM, Margaritopoulos GA, & Siafakas NM. (2013). Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future. Eur Respir Rev 22, 281-291
34. Skrovankova S, Misurcova L, & Machu L. (2012). Antioxidant activity, and protecting health effects of common medicinal plants. Adv Food Nutr Res 67, 75-139
35. Gonzalez-Munoz A, Quesille-Villalobos AM, Fuentealba C, et al. (2013). Potential of Chilean native corn (Zea mays L.) accessions as natural sources of phenolic antioxidants, and in vitro bioactivity for hyperglycemia, and hypertension management. J Agric Food Chem 61, 10995-11007
36. Di Carlo G, Mascolo N, Izzo AA, et al. (1999). Flavonoids: old, and new aspects of a class of natural therapeutic drugs. Life Sci 65, 337-353
37. Di Paola R, Talero E, Galuppo M, et al. (2011). Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis. Respir Res 12, 41
38. Galuppo M, Di Paola R, Mazzon E, et al. (2010). GW0742, a high affinity PPAR-beta/delta agonist reduces lung inflammation induced by bleomycin instillation in mice. Int J Immunopathol Pharmacol 23, 1033-1046
39. Hallgren R, Bjermer L, Lundgren R, et al. (1989). The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis 139, 373-377
40. Mastruzzo C, Crimi N, & Vancheri C. (2002). Role of oxidative stress in pulmonary fibrosis. Monaldi Arch Chest Dis 57, 173-176
41. Moncada S, Palmer RM, & Higgs EA. (1989). Biosynthesis of nitric oxide from L-Arginine. A pathway for the regulation of cell function, and communication. Biochem Pharmacol 38, 1709-1715
42. McCall TB, Boughton-Smith NK, Palmer RM, et al. (1989). Synthesis of nitric oxide from L-Arginine by neutrophils. Release, and interaction with superoxide anion. Biochem J 261, 293-296
43. Cuzzocrea S, Zingarelli B, Hake P, et al. (1998). Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase, and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 24, 450-459
44. Wei XQ, Charles IG, Smith A, et al. (1995). Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411
45. Gansauge S, Gansauge F, Nussler AK, et al. (1997). Exogenous, but not endogenous, nitric oxide increases proliferation rates in senescent human fibroblasts. FEBS Lett 410, 160-164
46. Romanska HM, Polak JM, Coleman RA, et al. (2002). iNOS gene upregulation is associated with the early proliferative response of human lung fibroblasts to cytokine stimulation. J Pathol 197, 372-379
47. Chiarugi A. (2002). Poly(ADP-ribose) polymerase: killer or conspirator?. The suicide hypothesis revisited. Trends Pharmacol Sci 23, 122-129
48. Jin HL, & Dong JC. (2011). Pathogenesis of idiopathic pulmonary fibrosis: from initial apoptosis of epithelial cells to lung remodeling?. Chin Med J 124, 4330-4338
49. Wallach-Dayan SB, Izbicki G, Cohen PY, et al. (2006). Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 290, L790-L796
50. Park GY, & Christman JW(2006) Involvement of cyclooxygenase-2, and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am J Physiol Lung Cell Mol Physiol 290, L797-L805
51. Zhang HX, Duan GL, Wang CN, et al. (2014). Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress. Pulm Pharmacol Ther 27, 150-155
52. McCubrey JA, Lahair MM, & Franklin RA. (2006). Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8, 1775-1789
53. Impellizzeri D, Bruschetta G, Di Paola R, et al. (2014). The antiinflammatory, and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease. Clin Nutr (epublication ahead of print version 27 November 2014
54. Torres M, & Forman HJ. (2003). Redox signaling, and the MAP kinase pathways. Biofactors 17, 287-296
55. Fagone E, Conte E, Gili E, et al. (2011). Resveratrol inhibits transforming growth factor-beta-induced proliferation, and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition, and PTEN restoration. Exp Lung Res 37, 162-174
56. Kundu JK, Shin YK, Kim SH, et al. (2006). Resveratrol inhibits phorbol ester-induced expression of COX-2, and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 27, 1465-1474
57. Wei ZQ, Yan L, Deng JG, et al. (2014). Mangiferin protects rats against chronic bronchitis via regulating NF-kappaB (P65), and IkappaBalpha expression in mononuclear cells. Yao Xue Xue Bao 49, 596-601